Bausch + Lomb Corporation - stock earnings
BLCO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | 0.07 / 0.08 | - | 1.1 billion / 1.1 billion | - |
| July 31, 2024 BeforeMarket | - / - | 1.6 billion | - / 1.6 billion | 1.6 billion |
BLCO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -167.0 million USD | 1.1 billion USD |
| 2023Q4 | -54.0 million USD | 1.2 billion USD |
| 2023Q3 | -84.0 million USD | 1.0 billion USD |
| 2023Q2 | -32.0 million USD | 1.0 billion USD |
| 2023Q1 | -88.0 million USD | 931.0 million USD |
| 2022Q4 | -1.0 million USD | 996.0 million USD |
| 2022Q3 | -15.0 million USD | 942.0 million USD |
| 2022Q2 | 7.0 million USD | 941.0 million USD |
| 2022Q1 | 20.0 million USD | 889.0 million USD |
| 2021Q4 | 51.0 million USD | 1.0 billion USD |
| 2021Q3 | 60.0 million USD | 949.0 million USD |
| 2021Q2 | 44.0 million USD | 934.0 million USD |
| 2021Q1 | 27.0 million USD | 881.0 million USD |
| 2020Q4 | -209.0 million USD | 944.0 million USD |
BLCO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -260.0 million USD | 4.1 billion USD |
| 2022 | 15.0 million USD | 3.8 billion USD |
| 2021 | 182.0 million USD | 3.8 billion USD |
| 2020 | -17.0 million USD | 3.4 billion USD |
| 2019 | 298.0 million USD | 3.8 billion USD |
| 2018 | 710.0 million USD | 3.7 billion USD |
BLCO
Price: $13.60
52 week price:
Earnings Per Share: -0.96 USD
P/E Ratio: -24.17
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 494000
Market Capitalization: 4.8 billion